A groundbreaking urine test capable of detecting lung cancer years before symptoms manifest could be available on the NHS within five years, according to scientists funded by Cancer Research UK.
How the test works
Researchers at the University of Cambridge have developed a sensor that identifies specific proteins produced by so-called 'zombie' cells in the lungs. These senescent cells are a hallmark of early-stage lung cancer, and the test releases a detectable compound into urine when they are present.
Potential to revolutionise diagnosis
Currently, most lung cancer cases in England are diagnosed at an advanced stage, when treatment options are limited and survival rates are low. This simple urine analysis could enable routine screening, catching the disease months or even years earlier.
Dr. Ella Pickover, reporting for the Independent, notes that the test may also be adapted for other lung diseases and cancers. Further clinical trials are required, but the potential impact on public health is significant.
- Non-invasive and easy to administer
- Could be used as a routine screening tool
- May detect other cancers in the future
This innovation builds on a 'trailblazing' NHS pilot that combines AI and robotics to spot lung cancer faster, highlighting the UK's commitment to early detection.
